Skip to content

    PCBL Chemical

    PCBL
    Chemicals·30 Apr 2026
    Management Summary

    PCBL Chemical navigated a challenging Q4 FY26 marked by geopolitical disruptions and cost pressures, yet showed signs of recovery with strong domestic volume growth and significant progress on strategic initiatives like capacity expansion and cost reduction. The company remains optimistic about FY27, targeting double-digit EBITDA growth and substantial improvements in Aquapharm's performance, while strengthening its balance sheet.

    Highlights

    5
    • Consolidated sales volume increased 8% YoY to 161,865 MT in Q4 FY26, driven by 21% YoY domestic sales growth.

    • Specialty sales volumes grew significantly by 26% YoY to 19,386 tons in Q4 FY26, indicating strong demand for high-value products.

    • Net borrowings reduced by INR 454 crores to INR 4,536 crores in FY26, despite funding INR 750 crores in capex, strengthening the balance sheet.

    • Cost reduction initiatives are on track to unlock INR 200-250 crores of savings over the next 4-6 quarters, enhancing future profitability.

    • Nanovace pilot plant is ready for commissioning, with commercial volumes expected by FY28, marking progress in a strategic new segment.

    Concerns

    4
    • West Asia conflict caused significant disruptions, leading to massive increases in logistics costs and feedstock prices, impacting margins.

    • International sales volume decreased 10% in Q4 FY26 to 56,800 tons, reflecting global trade challenges.

    • Aquapharm's Q4 FY26 EBITDA was only INR 29 crores, impacted by slower infrastructure activity and LPG supply disruptions.

    • Commissioning of the 1,000 MTPA Palej superconductive specialty black line was delayed due to gas shortage.

    Key financials

    Metrics

    10

    Periods

    2

    Headline

    7
    • Consolidated Revenue
      ₹2,066 Cr
    • Consolidated EBITDA
      ₹248 Cr
    • Carbon Black Sales Volume
      1,61,865 MT
      YoY+8%
    • Domestic Sales Volume
      1,05,055 tons
      YoY+21%
    • International Sales Volume
      56,800 tons
      YoY-10%

    FY26

    3
    • Consolidated Revenue
      ₹8,189 Cr
      YoY-2.6%
    • Consolidated EBITDA
      ₹1,081 Cr
      YoY-21.9%
    • Carbon Black Sales Volume
      6,18,956 MT
      YoY+3.8%

    Segment breakdown

    RevenueEBITDA
    Aquapharm (Q4 FY26)₹339 Cr₹29 Cr
    Aquapharm (FY26)₹1,443 Cr₹162 Cr
    Carbon Black (Q4 FY26)
    Heatmap· 2 shared metrics

    Capital allocation

    3
    high confidence
    CategoryHeadline
    Capex

    ₹750 crores

    Debt

    Net ₹4,536 crores

    Liquidity

    Liquidity disclosed

    Our working capital cycle has tightened further.

    Guidance & targets

    8
    CategoryTargetPriority
    Cost Savings
    Cost Savings
    INR 200-250 crores
    High
    Aquapharm Top-line Growth
    Aquapharm Top-line Growth
    20-25%
    High
    Aquapharm Profitability
    Aquapharm EBITDA Run Rate
    INR 75 crores per quarter
    High
    Carbon Black Volume
    Carbon Black Volume Growth
    high single-digit
    High
    Carbon Black Profitability
    Carbon Black EBITDA Growth
    more than double-digit
    High
    New Business Commercialization
    Nanovace Commercial Volumes
    commercial volumes going up
    High
    Long-term Profitability
    EBITDA
    INR 40 billion
    High
    EBITDA per ton
    EBITDA per ton increase
    14-15%
    High

    Full impact of cost pass-through

    Q2 FY27
    CurrentSpot market pass-through initiated, formula-based contracts have lag.
    TargetFull impact reflected in numbers, margins normalize.

    Why it matters

    Will normalize margins and reflect the company's ability to manage raw material price volatility.

    Given that price contracts carry an inherent quarterly lag effect, the full impact of cost pass-through will reflect in our numbers by Q2 FY27, at which point our margins profile should normalize.

    How to verify

    key_financials.metrics[label='Consolidated EBITDA']

    Risks & concerns

    4
    RiskSeverity

    West Asia Conflict and Supply Chain Disruptions

    Escalation of conflict led to massive increases in logistics costs, feedstock prices, and issues with ship availability, impacting 40% of export business.Management acknowledged

    high

    Crude Price Volatility

    Crude prices rose sharply from $60 to $100 per barrel, currently around $120, directly impacting raw material costs, though formula-based contracts have a lag effect.Management acknowledged

    medium

    Gas Shortage delaying Palej Specialty Black Line Commissioning

    The 1,000 MTPA superconductive specialty black line at Palej is mechanically ready but commissioning is delayed due to gas shortage.Management acknowledged

    medium

    Aquapharm Segment Challenges

    Aquapharm faced slower infrastructure activity, LPG supply disruption, and significant increases in raw material and packing material costs (25-30% for key raw materials, up to 1.5x for packing materials).Management acknowledged

    medium

    Q&A highlights

    8

    “Sanjesh, if you're comparing it with last quarter, it was not a usual quarter. And our profitability dipped significantly. So, while quarter-on-quarters, when you're looking, it is appearing as a significant jump, but this is not where we should be with the kind of volumes that we have done. And, of course, this quarter the volumes have gone up by 20,000 tons and the volumes have contributed. EBITDA margins remain the same. There's not much improvement at EBITDA per ton level. So, the real impact of all the initiatives which Nilesh just spoke about is yet to come. It is still not reflected in the performance.”

    Clarifies that Q4 profitability was more of a rebound from a low base rather than a significant structural improvement, setting expectations for future quarters.

    asked by Sanjesh Jain

    2 min read5 chapters

    Detailed Narrative

    01

    Navigating Geopolitical Headwinds and Supply Chain Disruptions

    PCBL Chemical faced significant challenges in Q4 FY26 due to the West Asia conflict, which escalated in February. This led to massive increases in logistics costs, feedstock prices, and issues with ship availability, impacting the 40% of business driven by exports. Raw material prices, particularly crude, rose sharply from $60 to $100 per barrel, currently hovering around $120 per barrel. Despite these pressures, the company proactively rerouted shipments to alternate geographies to ensure supply continuity, and customers were considerate in sharing increased costs.

    02

    Signs of Recovery and Strategic Initiatives in Carbon Black

    Management noted clear signs of recovery, with spreads finding a floor and positive exit quarter momentum. The rationalization of U.S. tariffs has restored a meaningful cost advantage for Indian exports, and customer pipelines in the specialty business are firming up. PCBL added 90,000 tons of carbon black capacity, bringing total installed capacity to 880,000 tons per annum. The company expects both domestic and export growth in coming quarters, with domestic sales volume growing 21% YoY to 105,055 tons in Q4 FY26, contributing to an overall 8% YoY increase in consolidated sales volume to 161,865 MT.

    03

    Aquapharm Segment Performance and Outlook

    The Aquapharm segment reported Q4 FY26 revenue of INR 339 crores and EBITDA of INR 29 crores, with full-year FY26 revenue at INR 1,443 crores and EBITDA at INR 162 crores. The segment faced headwinds from slower infrastructure activity and LPG supply disruptions, but home care sales volumes grew 11% YoY and application-specific solutions grew 18%. Management anticipates a strong top-line growth of 20-25% for Aquapharm in FY27, aiming for an EBITDA run rate of INR 75 crores per quarter within the next 2-3 quarters, driven by increased capacity utilization and recovery in the oil & gas business.

    04

    Advancements in Nanovace and Cost Optimization

    The pilot plant for Nanovace, PCBL's battery chemicals platform, is fully equipped and ready for commissioning, with commercial volumes expected by FY28 after a validation period. This represents a significant diversification opportunity into a high-growth, high-margin segment. Furthermore, cost reduction initiatives, focusing on yield improvement, throughput enhancement, and feedstock diversification, are on track to deliver INR 200-250 crores in savings over the next 4-6 quarters, which will significantly enhance future profitability and operational efficiency.

    05

    Balance Sheet Strengthening and Capacity Expansion Progress

    PCBL successfully reduced net borrowings by INR 454 crores to INR 4,536 crores during FY26, even while funding INR 750 crores of capex. The 90,000 tons Brownfield expansion for rubber carbon black in Tamil Nadu is complete, contributing to the increased capacity. However, the commissioning of the 1,000 MTPA superconductive specialty black line at Palej was delayed due to gas shortage, while the 20,000 tons specialty black line in Mudra is ready for commissioning in the coming weeks, indicating ongoing capacity additions.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.